Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy

OBJECTIVE: To evaluate the preventive effects of alkaline citrate on stone recurrence as well as stone growth post-ESWL or PCNL in patients with calcium-containing stones. MATERIALS AND METHODS: A total of 76 patients with calcium calculi who were stone-free or had residual stones less than 4 mm fol...

Full description

Bibliographic Details
Main Authors: B Lojanapiwat, M Tanthanuch, C Pripathanont, S Ratchanon, S Srinualnad, T Taweemonkongsap, S Kanyok, S Lammongkolkul
Format: Article
Language:English
Published: Sociedade Brasileira de Urologia 2011-10-01
Series:International Brazilian Journal of Urology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382011000500007
id doaj-bdc4e8ac68304d6c8340b370eeb45559
record_format Article
spelling doaj-bdc4e8ac68304d6c8340b370eeb455592020-11-24T23:54:57ZengSociedade Brasileira de UrologiaInternational Brazilian Journal of Urology1677-55381677-61192011-10-0137561161610.1590/S1677-55382011000500007Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomyB LojanapiwatM TanthanuchC PripathanontS RatchanonS SrinualnadT TaweemonkongsapS KanyokS LammongkolkulOBJECTIVE: To evaluate the preventive effects of alkaline citrate on stone recurrence as well as stone growth post-ESWL or PCNL in patients with calcium-containing stones. MATERIALS AND METHODS: A total of 76 patients with calcium calculi who were stone-free or had residual stones less than 4 mm following ESWL and PCNL were enrolled. All patients were independently randomized into two groups. The treated group (N = 39) was given 81 mEq per day of oral potassium-sodium citrate (27 mEq three times a day), and the untreated group (N = 37) serving as controls. Blood, twenty-four hour urine analysis, and plain KUB were measured and compared at the baseline and after 12 months. RESULTS: At baseline, hypocitraturia was found in 20 of 39 patients (46.05%) of Group I and 15 of 37 patients (40.5%) of Group II. At 12 months, hypocitraturia was found in 3 of 39 (7.69%) and 14 of 37 (37.83%) of Group I and Group II, respectively (p = 0.007). At the 12 month follow-up, of the stone-free group, 92.3% of the treated group and 57.7% of the control group were still stone free. Of the residual stone group, 30.8% and 9.1 % of treated and control group were stone-free, respectively. The increased stone size found in 7.7% and 54.5% of treated and control groups, respectively. CONCLUSION: Sodium-potassium citrate provides positive effects on stone-forming activities in calcium stone patients suffering from urolithiasis following treatment with ESWL and PCNL procedures at the 12-month follow-up.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382011000500007kidneycalculilithotripsycitratesurolithiasis
collection DOAJ
language English
format Article
sources DOAJ
author B Lojanapiwat
M Tanthanuch
C Pripathanont
S Ratchanon
S Srinualnad
T Taweemonkongsap
S Kanyok
S Lammongkolkul
spellingShingle B Lojanapiwat
M Tanthanuch
C Pripathanont
S Ratchanon
S Srinualnad
T Taweemonkongsap
S Kanyok
S Lammongkolkul
Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy
International Brazilian Journal of Urology
kidney
calculi
lithotripsy
citrates
urolithiasis
author_facet B Lojanapiwat
M Tanthanuch
C Pripathanont
S Ratchanon
S Srinualnad
T Taweemonkongsap
S Kanyok
S Lammongkolkul
author_sort B Lojanapiwat
title Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy
title_short Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy
title_full Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy
title_fullStr Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy
title_full_unstemmed Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy
title_sort alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy
publisher Sociedade Brasileira de Urologia
series International Brazilian Journal of Urology
issn 1677-5538
1677-6119
publishDate 2011-10-01
description OBJECTIVE: To evaluate the preventive effects of alkaline citrate on stone recurrence as well as stone growth post-ESWL or PCNL in patients with calcium-containing stones. MATERIALS AND METHODS: A total of 76 patients with calcium calculi who were stone-free or had residual stones less than 4 mm following ESWL and PCNL were enrolled. All patients were independently randomized into two groups. The treated group (N = 39) was given 81 mEq per day of oral potassium-sodium citrate (27 mEq three times a day), and the untreated group (N = 37) serving as controls. Blood, twenty-four hour urine analysis, and plain KUB were measured and compared at the baseline and after 12 months. RESULTS: At baseline, hypocitraturia was found in 20 of 39 patients (46.05%) of Group I and 15 of 37 patients (40.5%) of Group II. At 12 months, hypocitraturia was found in 3 of 39 (7.69%) and 14 of 37 (37.83%) of Group I and Group II, respectively (p = 0.007). At the 12 month follow-up, of the stone-free group, 92.3% of the treated group and 57.7% of the control group were still stone free. Of the residual stone group, 30.8% and 9.1 % of treated and control group were stone-free, respectively. The increased stone size found in 7.7% and 54.5% of treated and control groups, respectively. CONCLUSION: Sodium-potassium citrate provides positive effects on stone-forming activities in calcium stone patients suffering from urolithiasis following treatment with ESWL and PCNL procedures at the 12-month follow-up.
topic kidney
calculi
lithotripsy
citrates
urolithiasis
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382011000500007
work_keys_str_mv AT blojanapiwat alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy
AT mtanthanuch alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy
AT cpripathanont alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy
AT sratchanon alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy
AT ssrinualnad alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy
AT ttaweemonkongsap alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy
AT skanyok alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy
AT slammongkolkul alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy
_version_ 1725464188239740928